We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

593 hedge funds and large institutions have $2.46B invested in iShares US Medical Devices ETF in 2022 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 167 increasing their positions, 234 reducing their positions, and 84 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.08% more ownership

Funds ownership: 37.87%37.95% (+0.08%)

6% less funds holding

Funds holding: 632593 (-39)

17% less capital invested

Capital invested by funds: $2.96B → $2.46B (-$504M)

18% less funds holding in top 10

Funds holding in top 10: 2218 (-4)

27% less call options, than puts

Call options by funds: $14.6M | Put options by funds: $19.9M

29% less repeat investments, than reductions

Existing positions increased: 167 | Existing positions reduced: 234

39% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 84

Holders
593
Holders Change
-39
Holders Change %
-6.17%
% of All Funds
9.99%
Holding in Top 10
18
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-18.18%
% of All Funds
0.3%
New
51
Increased
167
Reduced
234
Closed
84
Calls
$14.6M
Puts
$19.9M
Net Calls
-$5.36M
Net Calls Change
-$6.43M
Name Holding Trade Value Shares
Change
Change in
Stake
SFA
276
Source Financial Advisors
New York
$678K -$30.2K -555 -4%
GM
277
GeoWealth Management
Illinois
$678K -$30.2K -554 -4%
PFA
278
Plotkin Financial Advisors
Maryland
$674K +$5.45K +100 +0.8%
CWM
279
Cornerstone Wealth Management
Missouri
$660K -$1.47M -26,888 -67%
LWP
280
Legacy Wealth Planning
Nevada
$655K
CWS
281
Cypress Wealth Services
California
$653K -$128K -2,342 -15%
QIM
282
Quantitative Investment Management
Virginia
$652K +$705K +12,929 New
MPW
283
MA Private Wealth
California
$651K -$720K -13,207 -50%
GLA
284
Good Life Advisors
Pennsylvania
$651K -$63.3K -1,161 -8%
WWA
285
WCG Wealth Advisors
Nevada
$646K +$698K +12,804 New
CIC
286
Cutler Investment Counsel
Oregon
$644K -$104K -1,907 -13%
Brown Advisory
287
Brown Advisory
Maryland
$641K
Qube Research & Technologies (QRT)
288
Qube Research & Technologies (QRT)
United Kingdom
$633K +$684K +12,542 New
WWM
289
Western Wealth Management
Colorado
$624K -$85.9K -1,577 -11%
MSFS
290
Main Street Financial Solutions
Pennsylvania
$622K -$5.23K -96 -0.8%
FWSM
291
First Wilshire Securities Management
California
$620K
C1AG
292
Client 1st Advisory Group
Florida
$617K -$115K -2,119 -15%
DE
293
Day & Ennis
Georgia
$608K -$19.9K -366 -3%
HFA
294
High Falls Advisors
New York
$585K +$128K +2,351 +25%
SFG
295
StrategIQ Financial Group
Indiana
$579K +$169K +3,094 +37%
T
296
TNF
Montana
$577K -$106K -1,950 -15%
KWM
297
Kingsview Wealth Management
Oregon
$574K -$91.3K -1,675 -13%
Koshinski Asset Management
298
Koshinski Asset Management
Illinois
$565K +$29.6K +544 +5%
MFA
299
Mayflower Financial Advisors
Massachusetts
$548K -$37.1K -681 -6%
GGI
300
GPM Growth Investors
Michigan
$546K -$40K -733 -6%

IHI Hedge Fund Activity: Q2 2022 in Review

593 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q2 2022, worth a combined $2.46B — down 17% from $2.96B a quarter earlier.

Sellers outnumbered buyers: 84 funds closed out of IHI and 51 opened new positions — a net loss of 33 holders — while 234 trimmed existing stakes and 167 added.

The largest buyer was AssetMark Inc, adding an estimated $78.4M. The largest seller was CFS Investment Advisory Services, cutting an estimated $88.9M.

  • 593 institutional investors held iShares US Medical Devices ETF (IHI) as of Q2 2022, down from 632 in Q1 2022.
  • Funds reported $2.46B of iShares US Medical Devices ETF stock for Q2 2022, down 17% quarter-over-quarter.
  • 51 funds opened new iShares US Medical Devices ETF positions in Q2 2022 and 84 closed out, a net change of -33 holders.
  • The largest iShares US Medical Devices ETF buyer in Q2 2022 was AssetMark Inc, an estimated $78.4M added.
  • The largest iShares US Medical Devices ETF seller in Q2 2022 was CFS Investment Advisory Services, an estimated $88.9M sold.

Based on aggregated 13F filings for Q2 2022.